SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

David W. Hutton · Study

Home/Author

David W. Hutton

6 works· latest 2021· 2 institutionscluster: provisionalORCID 0000-0001-9677-1632

h-index6

i106

Citations399

Works here6

13

14

17

20

21

Most cited in this library

Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms2020 · 161 citations
Cost effectiveness of regorafenib as second‐line therapy for patients with advanced hepatocellular carcinoma2017 · 84 citations
Switching To Less Expensive Blindness Drug Could Save Medicare Part B $18 Billion Over A Ten-Year Period2014 · 78 citations
Income and Income Inequality Are a Matter of Life and Death. What Can Policymakers Do About It?2021 · 35 citations
Evaluating Michigan’s Administrative Rule Change on Nonmedical Vaccine Exemptions2021 · 21 citations

Works

6 shown

Evaluating Michigan’s Administrative Rule Change on Nonmedical Vaccine Exemptions

PEDIATRICS·2021·7 authors·Open access

21citations

Income and Income Inequality Are a Matter of Life and Death. What Can Policymakers Do About It?

American Journal of Public Health·2021·7 authors·Open access

35citations

Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms

The American Journal of Gastroenterology·2020·4 authors·Open access

161citations

Cost effectiveness of regorafenib as second‐line therapy for patients with advanced hepatocellular carcinoma

Cancer·2017·3 authors·Open access

84citations

Switching To Less Expensive Blindness Drug Could Save Medicare Part B $18 Billion Over A Ten-Year Period

Health Affairs·2014·5 authors·Open access

78citations

Too Much of a Good Thing? When to Stop Catch-Up Vaccination

Medical Decision Making·2013·2 authors·Open access

20citations